Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 279.35 M267.65 M280.31 M322.33 M 1.15 B Research & development 576.45 M573.3 M583.2 M642.92 M 2.38 B Operating income 1.83 B1.81 B2.05 B2.51 B 8.2 B Non-Operating Income, Total 88.47 M71.53 M6.13 M62.66 M 228.78 M Interest expense, net of interest capitalized 42.47 M40.88 M39.33 M34.2 M 156.88 M Non-Operating Income, excl. Interest Expenses 15.92 M4.25 M2.26 M-13.2 M 9.22 M Unusual income/expense 30.07 M26.41 M-35.46 M41.65 M 62.68 M Pretax income 1.86 B1.84 B2.01 B2.56 B 8.26 B Equity in earnings ———— — Taxes 290.5 M242.62 M186.1 M277.86 M 997.08 M Non-controlling/minority interest ———— — After tax other income/expense 1.89 M19.96 M2.85 M8.01 M 32.71 M Net income before discontinued operations 1.57 B1.59 B1.83 B2.28 B 7.27 B Discontinued operations ———— — Net income 1.57 B1.59 B1.83 B2.28 B 7.27 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 1.57 B1.59 B1.83 B2.28 B 7.27 B Basic earnings per share (Basic EPS) 1.241.271.461.82 5.79 Diluted earnings per share (Diluted EPS) 1.241.261.451.81 5.76 Average basic shares outstanding 1.26 B1.25 B1.25 B1.26 B — Diluted shares outstanding 1.27 B1.26 B1.26 B1.26 B — EBITDA ———— — EBIT 4.47 B4.5 B4.98 B5.76 B 19.71 B Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —